Also trades as: LCTX.TA (TLV) · $vol 0M
LCTX AMEX
Lineage Cell Therapeutics, Inc.
1W: -9.8%
1M: -16.3%
3M: -30.1%
YTD: -43.4%
1Y: -45.0%
3Y: -21.9%
5Y: -63.9%
$0.93
+0.03 (+2.89%)
Weekly Expected Move ±9.0%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
4 relationships4
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2021-12-20
Earliest Filing
2024-03-22
Latest Filing
partner: 4
Counterparties (Filed by LCTX)
4 relationshipsCompanies named in LCTX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Cantor Fitzgerald & Co. | — | partner | Prior sales agent whose agreement with the Company was terminated. | 2024-03-22 | View |
| Genentech | RHHBY | partner | Exclusive worldwide collaboration and license agreement for OpRegen RPE cell therapy development and commercialization | 2021-12-20 | View |
| Roche | — | partner | Parent group of Genentech entering exclusive collaboration for OpRegen RPE cell therapy | 2021-12-20 | View |
| Cell Cure Neurosciences Ltd. | — | partner | Lineage subsidiary entering collaboration agreement with Roche and Genentech | 2021-12-20 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-06 | Earnings Release; Exhibits | View | |
| 2026-06-12 | Shareholder Vote; Other Events | View | |
| 2026-05-12 | Earnings Release; Exhibits | View | |
| 2026-03-11 | Other Events; Financial Statements and Exhibits | View | |
| 2026-03-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-28 | Other Events | View | |
| 2025-11-24 | Other Events | View | |
| 2025-11-12 | Other Events | View | |
| 2025-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-26 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-08-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-02 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2025-06-23 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-06-09 | Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits | View | |
| 2025-05-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-05-01 | Other Events | View | |
| 2025-03-10 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-01-27 | Submission of Matters to a Vote of Security Holders; Regulation FD Disclosure; Other Events; Financi | View | |
| 2024-11-20 | Entry into Material Definitive Agreement; Regulation FD Disclosure; Other Events; Financial Statemen | Agreement | View |
| 2024-11-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR